Goeltz II Robert C. (CIK 1653881) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-12). Recent activity: Sell RCUS (7,763 shares), Buy RCUS (24,000 shares), Sell RCUS (6,552 shares), Sell RCUS (6,702 shares), Sell RCUS (5,960 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-12 | Arcus Biosciences, Inc. (RCUS) | Chief Financial Officer | Sell | 7,763 | $198,966 |
| 2026-01-26 | Arcus Biosciences, Inc. (RCUS) | Chief Financial Officer | Buy | 24,000 | $0 |
| 2026-01-02 | Arcus Biosciences, Inc. (RCUS) | Chief Financial Officer | Sell | 6,552 | $153,186 |
| 2025-12-18 | Arcus Biosciences, Inc. (RCUS) | Chief Financial Officer | Sell | 6,702 | $146,640 |
| 2025-12-18 | Arcus Biosciences, Inc. (RCUS) | Chief Financial Officer | Sell | 5,960 | $132,074 |
| 2025-11-26 | Arcus Biosciences, Inc. (RCUS) | Chief Financial Officer | Sell | 5,000 | $125,000 |
| 2025-10-29 | Arcus Biosciences, Inc. (RCUS) | Chief Financial Officer | Sell | 5,000 | $100,000 |
| 2025-01-27 | Arcus Biosciences, Inc. (RCUS) | Chief Financial Officer | Buy | 37,000 | $0 |
Source: SEC Form 4 filings · as of 2026-05-12